Skip to content
‹ Back to IndustriesHealthcare

HIMSS 2023: Providers and Payers Maneuver “Too Much Data,” SDOH Initiatives, and “Hospital in the Home”

HIMSS 2023 was the host of several industry-defining conversations for the healthcare industry, including reflections on the growth of data use in healthcare and the evolution of how and where care is administered. The evolution of the healthcare marketplace has resulted in the saturation of data among multiple areas. As a result, the healthcare…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

HIMSS 2023 was the host of several industry-defining conversations for the healthcare industry, including reflections on the growth of data use in healthcare and the evolution of how and where care is administered.

The evolution of the healthcare marketplace has resulted in the saturation of data among multiple areas. As a result, the healthcare industry must be innovative in devising ways to channel this data in a meaningful way to serve their customers efficiently. From operations to validity and privacy, measures need to be taken to find a safe place for this data to reside.

Health equity and new initiatives buzzing around the retail community are sparking the possibility of ‘hospital in the home.’ The development of such programs will not only open more space in local hospitals but create a more comfortable environment for patients to recover in their own homes, giving healthcare organizations opportunities to channel data through remote devices.

Jonathan Wiik, Vice President of Healthcare Analytics at FinThrive, shares his takeaways from HIMSS 2023, and how these data and health equity goals are shaping out for payers and providers. has a great opportunity to capitalize on the dispersion of these different data sets, serving as a broker for these data transactions.

Jonathan’s Thoughts

“Spent the last four days here at HIMSS 2023. A lot of different themes I heard when I was here. Data, I would argue that the market is starting to realize it probably has too much data, trying to figure out exactly where it needs to go, right person, right time, right place to derive better outcomes with care and payment.

Sat in on several sessions today just understanding interoperability rules, data integrity rules, data validation rules, privacy rules, operationalizing where all that data needs to live and why.

From the payment side, saw lots and lots of discussions surrounding payer and provider transactions and what that looks like from a accountability standpoint. From the provider side of the payers, really want some transparency going back to the provider community surrounding payment rules and following that so they could do their jobs at managing care. Heard SDOH a lot. That was a buzzword two or three years ago. It’s back, baby. Social determinants of health is I think front and center as you’re looking at DEI and health equity initiatives.

I interviewed Alex Wendling from Utica University this morning, and he talked about how he has taken some data sets in state of New York and looked at how some of these social determinants datas can really drive health equity through Robert Wood Johnson Foundation, and what matters and why it’s important to understand those data sets and driving care.

Also talked with a gentleman, Geoffrey Roche, about some work that he’s done with AARP and in the state of Pennsylvania surrounding health equity and really being culturally competent at your organization to where you’re meeting the needs of others.

I’ve sat in on several sessions: Walmart, Best Buy, and all of those folks are here from the retail community really talking about hospital in the home. That’s another big theme I’ve heard here this week and where you’re seeing reimbursement kind of drive where they’re going to put technology. So hospitals are funding that infrastructure in terms of iPads, ethernet, those types of things to where patients can get better where they probably are the most comfortable which is right on their couch at home.

I’ve seen lots of discussions about prior authorization, some of the rules that are out there, that’s probably the bane of existence of most of the parties here, both on the payer and provider side. I think there’s huge opportunities for FinThrive in this space as we operate a lot in those data sets, are responsible for brokering a lot of those transactions between patient, provider, and payer, and looking really forward to taking a lot of these insights and applying them through our technologies as we move forward.”

Article written by Nakita Rowell-Stevens.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical acquires Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and one-million-square-foot Medolla, Italy manufacturing campus for $125 million base price plus up to $45 million contingent on revenue and EBITDA milestones.
  • 02Combined business targeted to generate $400-450 million in annual revenue depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512